BioLife Solutions, Inc.BLFSNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +29.69% | -119.69% | +29.88% | +28.94% | -8.19% |
| Gross Profit Growth | +81.79% | -8.71% | +28.96% | +24.43% | -13.88% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -1457.01% | +198.48% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +5.98% | +4.07% | +3.75% | +3.90% | +3.79% |
| Weighted Average Shares Diluted Growth | +5.98% | +7.16% | +3.75% | +3.90% | +5.52% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -28.82% | +0.00% | +14.07% | +27.11% |
| Free Cash Flow Growth | +0.00% | -56.17% | +0.00% | +2.95% | -24.02% |
| Receivables Growth | -27.03% | -50.86% | -50.65% | -44.31% | -39.49% |
| Inventory Growth | -25.78% | -33.24% | -36.50% | -14.79% | -13.53% |
| Asset Growth | -7.17% | -3.20% | -1.61% | +3.27% | +2.73% |
| Book Value per Share Growth | -7.50% | -0.71% | +1.94% | +3.95% | +4.72% |
| Debt Growth | -11.16% | -10.80% | -34.21% | -33.77% | -47.34% |
| R&D Expense Growth | -62.05% | -75.34% | -37.63% | +14.15% | +32.15% |
| SG&A Expenses Growth | -5.07% | -66.89% | +10.37% | +19.72% | -1.96% |